Literature DB >> 12668879

Prolactin replacement must be continuous and initiated prior to 21 d of age to maintain hypothalamic dopaminergic neurons in hypopituitary mice.

Carol J Phelps1, Mario I Romero, David L Hurley.   

Abstract

The prolactin (PRL) deficit in mice homozygous for the spontaneous Ames dwarf (df) mutation coincides with a marked reduction in the number of PRL-regulating tuberoinfundibular dopaminergic (TIDA) neurons. The TIDA deficit develops after 14 21 d postnatally and may be prevented by PRL replacement initiated at 12, but not at 60, d of age. The present study was designed to define further the developmental period during which PRL can prevent the deficit in the number of TIDA neurons in df/df mice, as well as to evaluate whether exposure to PRL neonatally affects the response to PRL by TIDA neurons in later development. To address the first aim, litters of df/df and normal (DF/df) mice were treated daily with ovine PRL (50 microg intraperitoneally), starting at 12, 21, or 30 d of age. To address the second aim, DF/df and df/df animals treated with PRL for 30 d starting at 12 d of age were subjected to PRL withdrawal (15 d of saline vehicle treatment), followed by PRL retreatment. All brains were evaluated using both catecholamine histofluorescence and tyrosine hydroxylase (TH) immunocytochemistry. Total numbers of TH-immunostained cells were counted in area A12 (TIDA neurons) and in A13 (medial zona incerta). Qualitatively, catecholamine fluorescence in A12 perikarya and terminals in df/df mice was enhanced by PRL treatment initiated at 12 or 21, but not at 30, d of age. TH immunostaining intensity was enhanced in all df/df PRL-treated groups, compared with saline treatment. However, total numbers of TH-positive TIDA neurons were reduced significantly in df/df mice treated with PRL beginning at 21 or 30 d, as well as with saline at 12 d, compared with similarly treated DF/df groups and with df/df animals treated with PRL beginning at 12 d (p < 0.01 for all comparisons). Among dwarf mice treated with PRL beginning at 12 d, followed by PRL withdrawal, the numbers of TH-positive TIDA neurons were greater than those of saline-treated dwarfs, but less than those in DF/df mice (p < 0.05 for both comparisons). In dwarfs retreated with PRL after withdrawal, the TIDA population was also smaller than that in normal animals (p < 0.05), although it was larger than in vehicle-treated dwarfs of the same age (p < 0.05).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668879     DOI: 10.1385/ENDO:20:1-2:139

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  40 in total

1.  Nuclear translocation of STAT5 and increased expression of Fos related antigens (FRAs) in hypothalamic dopaminergic neurons after prolactin administration.

Authors:  A Lerant; B Kanyicska; M E Freeman
Journal:  Brain Res       Date:  2001-06-22       Impact factor: 3.252

2.  Ontogeny of prolactin secretion in the neonatal rat is regulated posttranscriptionally.

Authors:  L S Frawley; H A Miller
Journal:  Endocrinology       Date:  1989-01       Impact factor: 4.736

3.  Atlas of the neurons that express mRNA for the long form of the prolactin receptor in the forebrain of the female rat.

Authors:  J C Bakowska; J I Morrell
Journal:  J Comp Neurol       Date:  1997-09-22       Impact factor: 3.215

4.  Hypothalamic dopaminergic neurons in prolactin-deficient Ames dwarf mice: localization and quantification of deficit by tyrosine hydroxylase immunocytochemistry.

Authors:  C J Phelps; S W Carlson; M Y Vaccarella
Journal:  J Neuroendocrinol       Date:  1994-04       Impact factor: 3.627

5.  Ontogeny of growth hormone and prolactin gene expression in mice.

Authors:  M B Slabaugh; M E Lieberman; J J Rutledge; J Gorski
Journal:  Endocrinology       Date:  1982-05       Impact factor: 4.736

6.  Release of dopamine from tuberoinfundibular neurons into pituitary stalk blood after prolactin or haloperidol administration.

Authors:  G A Gudelsky; J C Porter
Journal:  Endocrinology       Date:  1980-02       Impact factor: 4.736

7.  Further evidence for the existence of tubero-infundibular dopamine neurons.

Authors:  K Fuxe; T Hökfelt
Journal:  Acta Physiol Scand       Date:  1966 Jan-Feb

8.  Prolactin receptor mRNA localization in the hypothalamus by in situ hybridization.

Authors:  S Chiu; P M Wise
Journal:  J Neuroendocrinol       Date:  1994-04       Impact factor: 3.627

9.  Hypoprolactinemia induced by hypophysectomy and long-term bromocriptine treatment decreases tuberoinfundibular dopaminergic neuronal activity and the responsiveness of these neurons to prolactin.

Authors:  K T Demarest; G D Riegle; K E Moore
Journal:  Neuroendocrinology       Date:  1985-05       Impact factor: 4.914

10.  Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.

Authors:  G V Shah; S W Shyr; C E Grosvenor; W R Crowley
Journal:  Endocrinology       Date:  1988-05       Impact factor: 4.736

View more
  4 in total

1.  Transgenerational consequences of adolescent morphine exposure in female rats: effects on anxiety-like behaviors and morphine sensitization in adult offspring.

Authors:  Elizabeth M Byrnes
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

2.  Long-term, homologous prolactin, administered through ectopic pituitary grafts, induces hypothalamic dopamine neuron differentiation in adult Snell dwarf mice.

Authors:  Christina E Khodr; Sara M Clark; David L Hurley; Carol J Phelps
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

3.  MicroRNA-7a2 Regulates Prolactin in Developing Lactotrophs and Prolactinoma Cells.

Authors:  Mary P LaPierre; Svenja Godbersen; Mònica Torres Esteban; Anaïs Nura Schad; Mathias Treier; Umesh Ghoshdastider; Markus Stoffel
Journal:  Endocrinology       Date:  2021-02-01       Impact factor: 4.736

4.  Prolactin induces tuberoinfundibular dopaminergic neurone differentiation in Snell dwarf mice if administered beginning at 3 days of age.

Authors:  C E Khodr; D L Hurley; C J Phelps
Journal:  J Neuroendocrinol       Date:  2009-06       Impact factor: 3.627

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.